Decision

Allergan Inc. v. Sandoz Canada Inc., 2021 FC 186 (Silodosin*)

2021-02-26

Read full decision. Automatically generated summary:

These reasons and the accompanying Order concern the costs claimed in relation to the patent infringement action filed by the plaintiff Allergan against the defendant Sandoz, as well as the latter’s Counterclaim in this proceeding. For the reasons that follow, Allergan will be ordered to pay a lump sum amount of $384,505.69 to Sandoz, who ultimately prevailed in the main action. The legal fees component of this award ($272,000) represents approximately 45% of the fees incurred by Sandoz in connection with the issues in this proceeding, as ultimately narrowed.

Decision relates to:

  • T-2023-18 - ALLERGAN INC. v. SANDOZ CANADA INC. ET AL

 

Canadian Intellectual Property